Clinical trial
Immune and Viral Outcomes of HIV-1 Therapy Interruption
NCT00051818 is registered in ClinicalTrials.gov with The Wistar Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immune and Viral Outcomes of HIV-1 Therapy Interruption
- Lead sponsor
- The Wistar Institute
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 30, 2000
- Completion date
- July 31, 2003
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.